Norway Savings Bank’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$327K Sell
13,506
-958
-7% -$23.2K 0.17% 91
2025
Q1
$367K Sell
14,464
-1,584
-10% -$40.1K 0.21% 87
2024
Q4
$426K Buy
16,048
+124
+0.8% +$3.29K 0.24% 84
2024
Q3
$461K Sell
15,924
-2,765
-15% -$80K 0.25% 83
2024
Q2
$523K Buy
18,689
+425
+2% +$11.9K 0.3% 78
2024
Q1
$507K Sell
18,264
-2,815
-13% -$78.1K 0.21% 105
2023
Q4
$607K Sell
21,079
-3,133
-13% -$90.2K 0.27% 98
2023
Q3
$803K Sell
24,212
-947
-4% -$31.4K 0.4% 87
2023
Q2
$923K Sell
25,159
-1,997
-7% -$73.3K 0.5% 70
2023
Q1
$1.11M Sell
27,156
-995
-4% -$40.6K 0.56% 64
2022
Q4
$1.44M Sell
28,151
-56
-0.2% -$2.87K 0.73% 47
2022
Q3
$1.24M Sell
28,207
-1,890
-6% -$82.8K 0.67% 52
2022
Q2
$1.58M Sell
30,097
-805
-3% -$42.2K 0.82% 41
2022
Q1
$1.6M Sell
30,902
-155
-0.5% -$8.02K 0.72% 46
2021
Q4
$1.83M Buy
31,057
+335
+1% +$19.8K 0.8% 43
2021
Q3
$1.32M Buy
30,722
+2,044
+7% +$88K 0.62% 52
2021
Q2
$1.12M Sell
28,678
-508
-2% -$19.9K 0.55% 62
2021
Q1
$1.06M Buy
29,186
+50
+0.2% +$1.81K 0.56% 60
2020
Q4
$1.07M Sell
29,136
-166
-0.6% -$6.11K 0.62% 55
2020
Q3
$1.02M Buy
29,302
+2,624
+10% +$91.3K 0.69% 49
2020
Q2
$828K Buy
26,678
+2,567
+11% +$79.7K 0.61% 51
2020
Q1
$747K Buy
24,111
+3,135
+15% +$97.1K 0.65% 50
2019
Q4
$779K Buy
20,976
+5,233
+33% +$194K 0.57% 55
2019
Q3
$537K Buy
15,743
+1,718
+12% +$58.6K 0.44% 63
2019
Q2
$577K Sell
14,025
-715
-5% -$29.4K 0.49% 58
2019
Q1
$594K Sell
14,740
-211
-1% -$8.5K 0.52% 54
2018
Q4
$619K Buy
14,951
+177
+1% +$7.33K 0.61% 47
2018
Q3
$618K Sell
14,774
-614
-4% -$25.7K 0.54% 53
2018
Q2
$530K Sell
15,388
-5
-0% -$172 0.48% 56
2018
Q1
$518K Sell
15,393
-358
-2% -$12K 0.49% 55
2017
Q4
$541K Sell
15,751
-105
-0.7% -$3.61K 0.51% 54
2017
Q3
$537K Buy
15,856
+395
+3% +$13.4K 0.51% 54
2017
Q2
$493K Buy
15,461
+206
+1% +$6.57K 0.48% 56
2017
Q1
$495K Buy
15,255
+2,514
+20% +$81.6K 0.51% 57
2016
Q4
$393K Buy
+12,741
New +$393K 0.37% 69